FY26 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
Special Notice from FOOD AND DRUG ADMINISTRATION • HEALTH AND HUMAN SERVICES, DEPARTMENT OF. Place of performance: MD. Response deadline: Feb 24, 2026. Industry: NAICS 541714 • PSC AJ11.
Market snapshot
Baseline awarded-market signal across all contracting (sample of 400 recent awards; refreshed periodically).
Related hubs & trends
Navigate the lattice: hubs for browsing, trends for pricing signals.
Point of Contact
Agency & Office
More in NAICS 541714
Description
Amendment 02 - Save the date! the FY26 Virtual BAA day - 20 January 2026!
https://www.fda.gov/science-research/advancing-regulatory-science/2026-fda-broad-agency-announcement-day-01202026
Amendment 01 - Updated the announcement document to version 2.0. Changes are highlighted throughout the document.
In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement.
FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.
Files
Files size/type shown when available.
BidPulsar Analysis
A practical, capture-style breakdown of fit, requirements, risks, and next steps.
The FDA is seeking proposals for basic and applied research to advance regulatory science through the FY26 Broad Agency Announcement, as outlined in solicitation number FDABAA-26-00123. This effort includes various specific research areas aimed at enhancing scientific knowledge necessary for the FDA's mission. Notably, the Virtual BAA Day is scheduled for January 20, 2026, an important event for potential bidders to engage with the FDA.
The FDA aims to acquire research and development proposals that contribute to regulatory science and innovation, fulfilling its mission to protect and promote public health.
- Review specific research areas of interest in the BAA document.
- Prepare technical proposals responding to the FDA's outlined needs.
- Engage in networking at the FY26 Virtual BAA Day on January 20, 2026.
- Submit proposals by the February 24, 2026 deadline.
- Completed proposal format as per FDA guidelines.
- Clear description of research approach and objectives.
- Budget outline detailing cost for research activities.
- Relevant qualifications and experience of the research team.
- Compliance with the terms specified in the BAA.
Source coverage notes
Some notices publish limited source detail. Confirm these points before final bid/no-bid decisions.
- Specific research areas of interest are not detailed in the brief.
- No information on potential funding limits or ranges provided.
- Details regarding the evaluation criteria for proposals are absent.
FAQ
How do I use the Market Snapshot?
It summarizes awarded-contract behavior for the opportunity’s NAICS and sector, including a recent pricing band (P10–P90), momentum, and composition. Use it as context, not a guarantee.
Is the data live?
The signal updates as new awarded notices enter the system. Always validate the official award and solicitation details on SAM.gov.
What do P10 and P90 mean?
P10 is the 10th percentile award size and P90 is the 90th percentile. Together they describe the typical spread of award values.